| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Endocrinology and Metabolism, Vol 258, Issue 3 E482-E484, Copyright © 1990 by American Physiological Society
ARTICLES |
E. P. Gomez-Sanchez, C. M. Fort and C. E. Gomez-Sanchez
Research Service, J.A. Haley Veterans Administration Hospital, Tampa, Florida 33612.
The chronic intracerebroventricular (icv) infusion of aldosterone in rats and dogs elevates the blood pressure within 10-14 days at doses far below those that produce hypertension systemically. The effect in rats is dose dependent and blocked by the concomitant icv infusion of the antimineralocorticoid, prorenone. The effect of the icv infusion of RU28318, another specific spironolactone mineralocorticoid antagonist, on the hypertension produced by chronic subcutaneous (sc) administration of aldosterone in sensitized rats was reported. Miniosmotic pumps were used to deliver 1 micrograms/h aldosterone sc and 1.1 micrograms/h RU8318 icv. Over a 24-day period the indirect systolic blood pressure of the control, RU28318 icv, and aldosterone sc plus RU28318 icv groups increased from 105 to 123 mmHg and were not significantly different from each other, whereas the aldosterone sc group increased to 156 mmHg. RU28318, icv or sc, did not alter the increase in urine volume produced by aldosterone sc, and there was no significant differences in weight between the groups. This study provides evidence of the importance of the central nervous system in the pathogenesis of hypertension produced by systemic mineralocorticoid excess.
This article has been cited by other articles:
|
|
 |
|
  T. Matsukawa and T. Miyamoto Does infusion of ANG II increase muscle sympathetic nerve activity in patients with primary aldosteronism? Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1873 - R1879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-H. Zhang, Y. Yu, Y.-M. Kang, S.-G. Wei, and R. B. Felder Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H1067 - H1074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Jacob, L. A. Clark, P. A. Guzman, and J. W. Osborn Role of renal nerves in development of hypertension in DOCA-salt model in rats: a telemetric approach Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1519 - H1529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Gomez-Sanchez, N. Ahmad, D. G. Romero, and C. E. Gomez-Sanchez Is aldosterone synthesized within the rat brain? Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E342 - E346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Gomez-Sanchez, J. Samuel, G. Vergara, and N. Ahmad Effect of 3{beta}-hydroxysteroid dehydrogenase inhibition by trilostane on blood pressure in the Dahl salt-sensitive rat Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R389 - R393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, B. S. Huang, and F. H. H. Leenen Brain sodium channels and ouabainlike compounds mediate central aldosterone-induced hypertension Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2516 - H2523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kitagawa, J. Yanagisawa, H. Fuse, S. Ogawa, Y. Yogiashi, A. Okuno, H. Nagasawa, T. Nakajima, T. Matsumoto, and S. Kato Ligand-Selective Potentiation of Rat Mineralocorticoid Receptor Activation Function 1 by a CBP-Containing Histone Acetyltransferase Complex Mol. Cell. Biol., June 1, 2002; 22(11): 3698 - 3706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ngarmukos and R. J. Grekin Nontraditional aspects of aldosterone physiology Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1122 - E1127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. De Wardener The Hypothalamus and Hypertension Physiol Rev, October 1, 2001; 81(4): 1599 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Rahmouni, M. Barthelmebs, M. Grima, J.-L. Imbs, and W. De Jong Involvement of Brain Mineralocorticoid Receptor in Salt-Enhanced Hypertension in Spontaneously Hypertensive Rats Hypertension, October 1, 2001; 38(4): 902 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Alzamora, L. Michea, and E. T. Marusic Role of 11{beta}-Hydroxysteroid Dehydrogenase in Nongenomic Aldosterone Effects in Human Arteries Hypertension, May 1, 2000; 35(5): 1099 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Rahmouni, M. Barthelmebs, M. Grima, J.-L. Imbs, and W. De Jong Brain Mineralocorticoid Receptor Control of Blood Pressure and Kidney Function in Normotensive Rats Hypertension, May 1, 1999; 33(5): 1201 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. FITZSIMONS Angiotensin, Thirst, and Sodium Appetite Physiol Rev, July 1, 1998; 78(3): 583 - 686. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
